Immune Design Corp (NASDAQ:IMDZ) – Research analysts at Jefferies Group raised their FY2021 earnings per share estimates for Immune Design Corp in a report released on Thursday. Jefferies Group analyst M. Raycroft now anticipates that the biotechnology company will post earnings of $1.11 per share for the year, up from their prior forecast of $1.06. […]
